4.6 Review

Recent advances in oridonin derivatives with anticancer activity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Natural product-based nanoformulations for cancer therapy: Opportunities and challenges

Dharambir Kashyap et al.

Summary: The application of natural product-based nanoformulations in the treatment of various human diseases, such as cancer, is a growing field. Nanotechnology in cancer therapeutics has overcome the limitations of conventional drug delivery systems, with promising results in targeting tumor cells and reducing side effects. The integration of phytotherapy and nanotechnology in clinical settings may lead to better pharmacological responses and improved clinical outcomes for patients.

SEMINARS IN CANCER BIOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

The ever-increasing importance of cancer as a leading cause of premature death worldwide

Freddie Bray et al.

Summary: CVD and cancer are now leading causes of premature death in 127 countries with cancer poised to overtake CVD in most countries over the course of this century. Governments must consider these transitions in disease profiles when developing cancer policies at the local level.

CANCER (2021)

Review Chemistry, Medicinal

Recent progress of oridonin and its derivatives for cancer therapy and drug resistance

Yong-Feng Guan et al.

Summary: Oridonin, derived from traditional Chinese medicine Isodon rubescens, shows various biological functions such as anticancer, anti-inflammation, and antibacterial properties. Despite multiple anticancer mechanisms, its poor pharmaceutical properties have hindered its clinical research and application. Researchers are working to improve oridonin's pharmaceutical properties for potential anticancer use.

MEDICINAL CHEMISTRY RESEARCH (2021)

Review Pharmacology & Pharmacy

Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity

Xiang Li et al.

Summary: Oridonin, a natural terpenoid found in traditional Chinese herbal medicine, possesses a wide range of pharmacological properties such as anticancer and anti-inflammatory activities. However, its specific mechanism against related diseases is still unclear, and it may exhibit toxicity under specific circumstances, sparking debate and concern about its safety. Future research directions should focus on investigating the interrelationship between concentration and pharmacological effects as well as toxicity, reducing pharmacological toxicity, and modifying its structure to enhance pharmacological activity and bioavailability.

FRONTIERS IN PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance

Xi Liu et al.

Summary: Cancer is a major global health issue, with chemotherapy being the primary treatment option. Oridonin and its derivatives have shown promise in overcoming therapeutic resistance in cancer treatment, with potential as clinical trial drug candidates.

GENES & DISEASES (2021)

Article Medicine, General & Internal

Oridonin inhibits epithelial-mesenchymal transition of human nasopharyngeal carcinoma cells by negatively regulating AKT/STAT3 signaling pathway

Wei Liu et al.

Summary: The study demonstrated that oridonin inhibits migration and invasion of nasopharyngeal carcinoma cells through negatively regulating the AKT/STAT3 signaling pathway, suggesting that AKT/STAT3 signaling may be a potential therapeutic target for oridonin against nasopharyngeal carcinoma.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)

Article Chemistry, Medicinal

Hydrogen sulfide releasing oridonin derivatives induce apoptosis through extrinsic and intrinsic pathways

Haonan Li et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Solubility and Bioavailability Enhancement of Oridonin: A Review

Yuanyuan Zhang et al.

MOLECULES (2020)

Review Plant Sciences

Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019

David J. Newman et al.

JOURNAL OF NATURAL PRODUCTS (2020)

Article Chemistry, Medicinal

Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer

Hong Yao et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Natural Products as Modulators of Sirtuins

Berin Karaman Mayack et al.

MOLECULES (2020)

Article Nutrition & Dietetics

Oridonin Improves the Sensitivity of Multiple Myeloma Cells to Bortezomib through the PTEN/PI3K/Akt Pathway

Hong Wu et al.

CURRENT TOPICS IN NUTRACEUTICAL RESEARCH (2020)

Article Biochemistry & Molecular Biology

Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways

Jin-Huan Jiang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Biochemistry & Molecular Biology

ROS/JNK/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells

Di Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Oncology

Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity

Wei Hou et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Synergistic antitumor activity of oridonin and valproic acid on HL-60 leukemia cells

Wei Li et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Design and synthesis of novel oridonin analogues as potent anticancer agents

Qing-Kun Shen et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)

Article Pharmacology & Pharmacy

Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses

Onat Kadioglu et al.

FRONTIERS IN PHARMACOLOGY (2018)

Article Medicine, Research & Experimental

Oridonin enhances the radiosensitivity of lung cancer cells by upregulating Bax and downregulating Bcl-2

Sirui Li et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)

Article Oncology

Oridonin promotes G2/M arrest in A549 cells by facilitating ATM activation

Mingxing Zheng et al.

MOLECULAR MEDICINE REPORTS (2017)

Article Dentistry, Oral Surgery & Medicine

Oridonin induces apoptosis in human oral cancer cells via phosphorylation of histone H2AX

In-Hyoung Yang et al.

EUROPEAN JOURNAL OF ORAL SCIENCES (2017)

Review Chemistry, Multidisciplinary

The value of pyrans as anticancer scaffolds in medicinal chemistry

Dinesh Kumar et al.

RSC ADVANCES (2017)

Review Chemistry, Medicinal

Discovery and development of natural product oridonin-inspired anticancer agents

Ye Ding et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Review Biochemistry & Molecular Biology

Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound

Dahong Li et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Article Medicine, Research & Experimental

Protective effects of oridonin on the sepsis in mice

Yan-Jun Zhao et al.

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2016)

Article Biochemistry & Molecular Biology

Antitumor and Antibacterial Derivatives of Oridonin: A Main Composition of Dong-Ling-Cao

Dahong Li et al.

MOLECULES (2016)

Article Biotechnology & Applied Microbiology

Oridonin suppress cell migration via regulation of nonmuscle myosin IIA

Yin-Chao Li et al.

CYTOTECHNOLOGY (2016)

Article Biochemistry & Molecular Biology

Oridonin induces apoptosis in uveal melanoma cells by upregulation of Bim and downregulation of Fatty Acid Synthase

Zhimin Gu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Surgery

Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis

Fredrick J. Bohanon et al.

JOURNAL OF SURGICAL RESEARCH (2014)

Article Chemistry, Medicinal

Novel Hybrids of Natural Oridonin-Bearing Nitrogen Mustards as Potential Anticancer Drug Candidates

Shengtao Xu et al.

ACS MEDICINAL CHEMISTRY LETTERS (2014)

Review Pharmacology & Pharmacy

Amino acids as promoieties in prodrug design and development

Balvinder S. Vig et al.

ADVANCED DRUG DELIVERY REVIEWS (2013)

Article Chemistry, Medicinal

Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation

Dahong Li et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)

Article Immunology

Oridonin suppresses transplant rejection by depleting T cells from the periphery

Wenzhi Guo et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2013)

Article Gastroenterology & Hepatology

The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells

Hiu-Yee Kwan et al.

JOURNAL OF GASTROENTEROLOGY (2013)

Article Chemistry, Multidisciplinary

Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma

Wen Xu et al.

ACTA PHARMACOLOGICA SINICA (2006)

Article Gastroenterology & Hepatology

Oridonin inhibits cell growth by induction of apoptosis on human hepatocelluar carcinoma BEL-7402 cells

Jun-Feng Zhang et al.

HEPATOLOGY RESEARCH (2006)